Total Visits

Views
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial.259

Total Visits Per Month

March 2021April 2021May 2021June 2021July 2021August 2021September 2021
Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial.2232562

File Downloads

Views
Earl_et_al-2017-The_Lancet_Oncology-AM.pdf621

Top country views

Views
United States72
United Kingdom59
Germany44
France33
China17
India6
South Korea4
Poland4
Spain2
Italy2

Top cities views

Views
Ashburn34
Coventry25
Boardman8
Fairfield7
Cambridge4
Dallas3
Guangzhou3
London3
Polska3
Beijing2